AU2002368044A1 - Co-stimulatory molecules - Google Patents

Co-stimulatory molecules

Info

Publication number
AU2002368044A1
AU2002368044A1 AU2002368044A AU2002368044A AU2002368044A1 AU 2002368044 A1 AU2002368044 A1 AU 2002368044A1 AU 2002368044 A AU2002368044 A AU 2002368044A AU 2002368044 A AU2002368044 A AU 2002368044A AU 2002368044 A1 AU2002368044 A1 AU 2002368044A1
Authority
AU
Australia
Prior art keywords
stimulatory molecules
stimulatory
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368044A
Other languages
English (en)
Other versions
AU2002368044A8 (en
Inventor
Doris Apt
Jean Chia-Chun Chang
Claes Gustafsson
Alexandra L. L. Lazetic
Steven R. Leong
Juha Punnonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen Inc
Original Assignee
Maxygen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/888,324 external-priority patent/US7094875B2/en
Priority claimed from US10/032,214 external-priority patent/US7183376B2/en
Application filed by Maxygen Inc filed Critical Maxygen Inc
Publication of AU2002368044A1 publication Critical patent/AU2002368044A1/en
Publication of AU2002368044A8 publication Critical patent/AU2002368044A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002368044A 2001-06-22 2002-06-21 Co-stimulatory molecules Abandoned AU2002368044A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/888,324 US7094875B2 (en) 2000-06-23 2001-06-22 Co-stimulatory polypeptides
PCT/US2001/019973 WO2002000717A2 (fr) 2000-06-23 2001-06-22 Nouvelles molecules costimulatrices
AUPCT/US2001/019973 2001-06-22
US09/888,324 2001-06-22
US10/032,214 2001-12-20
US10/032,214 US7183376B2 (en) 2000-06-23 2001-12-20 Variant B7 co-stimulatory molecules
PCT/US2002/019898 WO2004029197A2 (fr) 2001-06-22 2002-06-21 Nouvelles molecules co-stimulatrices

Publications (2)

Publication Number Publication Date
AU2002368044A1 true AU2002368044A1 (en) 2004-04-19
AU2002368044A8 AU2002368044A8 (en) 2004-04-19

Family

ID=56290305

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368044A Abandoned AU2002368044A1 (en) 2001-06-22 2002-06-21 Co-stimulatory molecules

Country Status (3)

Country Link
EP (1) EP1497426A2 (fr)
AU (1) AU2002368044A1 (fr)
WO (1) WO2004029197A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015013557B1 (pt) 2012-12-11 2021-12-14 Albert Einstein College Of Medicine Sistema, método, método para determinar o efeito de um resíduo de aminoácido predeterminado de uma primeira proteína sobre a ligação da primeira proteína a uma segunda proteína e polipeptídeo pd-l1 mutante
KR20180012260A (ko) 2015-04-17 2018-02-05 알파인 이뮨 사이언시즈, 인코포레이티드 조율가능한 친화성을 갖는 면역조절 단백질
KR20180069903A (ko) 2015-11-02 2018-06-25 파이브 프라임 테라퓨틱스, 인크. Cd80 세포외 도메인 폴리펩타이드 및 이들의 암 치료에서의 용도
CN109715657A (zh) 2016-04-15 2019-05-03 高山免疫科学股份有限公司 Cd80变体免疫调节蛋白及其用途
IL262606B2 (en) 2016-05-18 2023-04-01 Albert Einstein College Medicine Inc pd-l1 variant polypeptides, T-cell modulatory multimeric polypeptides, and methods of using them
KR20190019068A (ko) * 2016-05-18 2019-02-26 큐 바이오파마, 인크. T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
WO2018022945A1 (fr) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Protéines immunomodulatrices à variants de cd112 et utilisations associées
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
DK3558339T3 (da) 2016-12-22 2024-02-26 Cue Biopharma Inc T-celle-modulerende multimere polypeptider og fremgangsmåder til anvendelse deraf
WO2018129474A1 (fr) 2017-01-09 2018-07-12 Cue Biopharma, Inc. Polypeptides multimères modulateurs de lymphocytes t et leurs procédés d'utilisation
US20200010528A1 (en) 2017-03-15 2020-01-09 Cue Biopharma, Inc. Methods for modulating an immune response
WO2018170026A2 (fr) * 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Protéines immunomodulatrices à variants de cd80 et leurs utilisations
CN110809581A (zh) 2017-03-16 2020-02-18 高山免疫科学股份有限公司 Pd-l2变体免疫调节蛋白及其用途
WO2018201014A1 (fr) 2017-04-28 2018-11-01 Five Prime Therapeutics, Inc. Méthodes de traitement avec des polypeptides du domaine extracellulaire de cd80
TW201925223A (zh) 2017-10-18 2019-07-01 美商艾爾潘免疫科學有限公司 變異型icos 配位體免疫調節蛋白及相關組合物及方法
EP3737689A4 (fr) 2018-01-09 2021-12-01 Cue Biopharma, Inc. Polypeptides multimères modulateurs de lymphocytes t et leurs procédés d'utilisation
WO2020010284A1 (fr) * 2018-07-04 2020-01-09 Cytoimmune Therapeutics, LLC Compositions et méthodes d'immunothérapie ciblant flt3, pd-1 et/ou pd-l1
JP2022501361A (ja) * 2018-09-19 2022-01-06 アルパイン イミューン サイエンシズ インコーポレイテッド バリアントｃｄ８０融合タンパク質および関連構築物の方法および使用
CA3169949A1 (fr) 2020-05-12 2021-11-18 Cue Biopharma, Inc. Polypeptides multimeres modulateurs de lymphocytes t et leurs methodes d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429303B1 (en) * 1999-09-03 2002-08-06 Curagen Corporation Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
CA2411828A1 (fr) * 2000-06-23 2002-01-03 Maxygen, Inc. Nouvelles molecules costimulatrices

Also Published As

Publication number Publication date
WO2004029197A8 (fr) 2005-07-21
EP1497426A2 (fr) 2005-01-19
WO2004029197A3 (fr) 2004-10-28
WO2004029197A2 (fr) 2004-04-08
AU2002368044A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AU2002313565A1 (en) Putter-heads
AU2002368044A1 (en) Co-stimulatory molecules
AU2002245332A1 (en) Anergy-regulated molecules
AU2002337312A1 (en) Molecules
AU2002359320A1 (en) Novel anit-infectives
AU2002319532A1 (en) Feeding-bottles
AU2002313943A1 (en) Electromobile
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AU2002313073A1 (en) Phytocystatin
AU2002257925A1 (en) Numberplates
AU2001100522A4 (en) e-Trans
AU2001100338A4 (en) Sunglove
AU2001100214A4 (en) Dolly-trolley
AU2001100532A4 (en) FonePark
AU2002100746A4 (en) Adrail
AU2002316594A1 (en) Minimizing spatial-dispersion-induced birefringence
AUPR754901A0 (en) Masta technologies
AU2002254979A1 (en) Novel sulfonylamino-pyrimidines
AU2002253663A1 (en) Novel maxizyme
AU2002355888A1 (en) Novel combination
AU2002249693A1 (en) Starseparator
AU2002321547A1 (en) Beta-ketophosphonates
AU2002233177A1 (en) Ejectorsystem
AU2002253687A1 (en) Floss-pick

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase